{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:12:19Z","timestamp":1792026739989,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Science and Technology Projects in Guangzhou","award":["2023A03J1000"],"award-info":[{"award-number":["2023A03J1000"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:p>Nucleic acid amplification testing (NAT) is a highly sensitive and specific testing technology for bloodborne infectious diseases. Since 2010, blood collection and supply institutions in China have widely adopted NAT technology for blood screening, greatly enhancing blood safety. Basing it on comparison with established quality systems in serological testing processes, we aimed to establish and continuously improve a quality monitoring system that meets the requirements of NAT procedure. Statistical analysis was conducted using the daily performance data of the Grifols Procleix Panther nucleic acid testing system in the laboratory from 2021 to 2022, including test frequency reactive rate, invalid test rate, system failures frequency, and laboratory contamination monitoring indicators. In 2021 and 2022, the annual discriminated rate on NAT yield donation were 39.11% and 39.29%, respectively. The average annual invalid test rates for the 4 units of Grifols Panther systems were 1.80%, 1.47%, 1.60%, and 1.51%, resulting in an overall invalid test rate of 1.60% (7881\/493, 137). A total of 377 invalid runs occurred, with the most frequent invalid test reasons being 64 instances of insufficient internal control detection (\u201clow internal control\u201d), 55 instances of issues with verifying the volume of target capture reagent\u2005+\u2005samples (\u201cVVFS\u201d), and 49 instances of the presence of clots detected during aspiration (\u201cCLT\u201d). The most significant contributor to invalid test counts was pipette malfunction (\u201cPMFR\u201d), which accounted for 2136 invalid tests. In the laboratory contamination monitoring, a total of 792 monitoring tests were conducted over a 2-year period, during which hepatitis B virus DNA was detected once in a specimen centrifuge cup. Establishing systematic quality monitoring indicators can effectively and promptly identify potential quality risk factors, thereby ensuring the quality of blood testing.<\/jats:p>","DOI":"10.1097\/md.0000000000043463","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T09:00:34Z","timestamp":1753952434000},"page":"e43463","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective analysis of quality monitoring indexes of Grifols Panther nucleic acid detection system"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0722-3617","authenticated-orcid":false,"given":"Bo Quan","family":"Huang","sequence":"first","affiliation":[{"name":"Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China"},{"name":"The Key Medical Laboratory of Guangzhou, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1932-8763","authenticated-orcid":false,"given":"Jun Mou","family":"Xie","sequence":"additional","affiliation":[{"name":"Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China"},{"name":"The Key Medical Laboratory of Guangzhou, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Jian","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China"},{"name":"The Key Medical Laboratory of Guangzhou, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6547-5648","authenticated-orcid":false,"given":"Lan Yin","family":"Lan","sequence":"additional","affiliation":[{"name":"Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China"},{"name":"The Key Medical Laboratory of Guangzhou, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2463-6340","authenticated-orcid":false,"given":"Xia","family":"Rong","sequence":"additional","affiliation":[{"name":"Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China"},{"name":"The Key Medical Laboratory of Guangzhou, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000457965","article-title":"Three-year experience in NAT screening of blood donors for transfusion transmitted viruses in croatia.","volume":"44","author":"Safic stanic","year":"2017","journal-title":"Transfus Med Hemother"},{"key":"R2-20251014","doi-asserted-by":"crossref","first-page":"1366431","DOI":"10.3389\/fpubh.2024.1366431","article-title":"Establishing a screening strategy for non-discriminatory reactive blood donors by constructing a predictive model of hepatitis B virus infection status from a single blood center in China.","volume":"12","author":"Wu","year":"2024","journal-title":"Front Public Health"},{"key":"R3-20251014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/vox.13592","article-title":"International review of blood donation nucleic acid amplification testing.","volume":"119","author":"Faddy","year":"2024","journal-title":"Vox Sang"},{"key":"R4-20251014","doi-asserted-by":"crossref","first-page":"116240","DOI":"10.1016\/j.diagmicrobio.2024.116240","article-title":"The prevalence of occult hepatitis B infection among the blood donors in a donation center in Beijing.","volume":"109","author":"Wang","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R5-20251014","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/trf.16420","article-title":"Blood donor screening in the Netherlands: universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.","volume":"61","author":"Van de laar","year":"2021","journal-title":"Transfusion"},{"key":"R6-20251014","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/trf.16675","article-title":"Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: a review of observed versus modeled infectivity from donors with window period and occult HBV infections.","volume":"61","author":"Lelie","year":"2021","journal-title":"Transfusion"},{"key":"R7-20251014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2543156","article-title":"Comparison of procleix ultrio elite and procleix ultrio NAT assays for screening of transfusion transmitted infections among blood donors in India.","volume":"2016","author":"Chaurasia","year":"2016","journal-title":"Int J Microbiol"},{"key":"R8-20251014","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/vox.12890","article-title":"Detection of hepatitis B virus infection in German blood donors 2008-2015.","volume":"115","author":"Scheiblauer","year":"2020","journal-title":"Vox Sang"},{"key":"R10-20251014","first-page":"1902","article-title":"Analysis of quality monitoring indicators in nucleic acid testing laboratories of blood stations.","volume":"42","author":"Liu","year":"2021","journal-title":"Int J Laboratory Med (in Chinese)"},{"key":"R11-20251014","first-page":"735","article-title":"Retrospective analysis and strategies for quality control indicators of clinical blood use in Zhejiang Province.","volume":"20","author":"Wang","year":"2022","journal-title":"General Med"},{"key":"R12-20251014","first-page":"625","article-title":"Analysis of invalid results in Panther nucleic acid testing.","volume":"32","author":"Huang","year":"2019","journal-title":"J Clin Hematol"},{"key":"R13-20251014","first-page":"463","article-title":"Quality monitoring indicators and analysis of the nucleic acid testing laboratory at the Rizhao Central Blood Station from 2016 to 2020.","volume":"20","author":"Yuan","year":"2022","journal-title":"J Commun Med"},{"key":"R14-20251014","first-page":"3304","article-title":"Quality monitoring indicators and analysis of invalid results in nucleic acid testing laboratories of blood stations.","volume":"17","author":"Han","year":"2020","journal-title":"J Laboratory Med Clin Sci"},{"key":"R15-20251014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12879-020-05747-4","article-title":"Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.","volume":"21","author":"Ye","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R16-20251014","first-page":"1110","article-title":"Confirmation of HBV infection status in HBsAg-negative NAT-suspicious specimens from blood donors.","volume":"36","author":"Wang","year":"2020","journal-title":"Chin J Blood Transfusion"},{"key":"R17-20251014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000496749","article-title":"History and future of nucleic acid amplification technology blood donor testing.","volume":"46","author":"Roth","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"R18-20251014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhep.2021.08.018","article-title":"Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma.","volume":"76","author":"Cordes","year":"2022","journal-title":"J Hepatol"},{"key":"R19-20251014","first-page":"724","article-title":"Retrospective analysis of nucleic acid screening data from centralized blood testing in the Tibet region.","volume":"36","author":"Li","year":"2023","journal-title":"Chin J Blood Transfus"},{"key":"R20-20251014","first-page":"509","article-title":"Assessment of residual HIV transmission risk in voluntary blood donors in Changsha.","volume":"25","author":"Hu","year":"2023","journal-title":"Clin Transfus Testing"},{"key":"R21-20251014","first-page":"2799","article-title":"Discussion on the application of viral nucleic acid testing and its quality control methods in voluntary blood donors.","volume":"15","author":"Gao","year":"2023","journal-title":"J Laboratory Med Clin Sci"},{"key":"R22-20251014","first-page":"399","article-title":"Discussion on quality monitoring indicators for nucleic acid testing laboratories.","volume":"32","author":"Fang","year":"2019","journal-title":"Chin J Blood Transfus"},{"key":"R23-20251014","first-page":"291","article-title":"Analysis of invalid results in the pooled nucleic acid testing model in blood station laboratories of the Beijing-Tianjin-Hebei region.","volume":"33","author":"Bai","year":"2020","journal-title":"Chin J Blood Transfus"},{"key":"R24-20251014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000446217","article-title":"Evaluation of the procleix ultrio elite assay and the panther-system for individual NAT screening of blood, hematopoietic stem cell, tissue and organ donors.","volume":"43","author":"Heim","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"R25-20251014","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0956462418764482","article-title":"Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.","volume":"29","author":"Hokynar","year":"2018","journal-title":"Int J STD AIDS"},{"key":"R26-20251014","first-page":"1","article-title":"Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in India.","volume":"10","author":"Rajput","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R27-20251014","first-page":"77","article-title":"Analysis of the causes of invalid results in nucleic acid testing for blood screening.","volume":"30","author":"Chen","year":"2017","journal-title":"Chin J Blood Transfus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:00:54Z","timestamp":1760461254000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":26,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043463","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"2024-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}